Table 2.

Descriptive statistics of the patient interval (n = 1878^a and primary care interval (n = 2194^a) in symptomatic women with breast cancer. Quantile regression modelling output is presented in the Supplementary material.

Symptom group	Median (IQR) 90th	P-value	% women >90 days (95% CI)
Patient Intervala
All women	7 (1–28) 80	–	9% (8–10%)
Breast lump only	7 (1–24) 66	<0.001b	7% (6–9%)
Non-lump only	12 (2–46) 126		15% (11–20%)
Lump and non-lump	14 (3–54) 276		20% (14–29%)
Non-breast symptoms	4 (0–18) 59		6% (2–12%)
White	7 (1–28) 80	0.509c	9% (8–10%)
Non-white	6 (0–30) 78		8% (5–14%)
<50 years	7 (1–27) 66	0.148c	7% (5–10%)
50–69 years	7 (1–25) 72		8% (6–10%)
70+ years	7 (1–31) 92		11% (9–13%)
Primary Care Intervala
All women	0 (0–1) 7	–	2% (1–2%)
Breast lump only	0 (0–0) 2	<0.001b	1% (1–2%)
Non-lump only	0 (0–1) 21		1% (0.4–4%)
Lump and non-lump	0 (0–1) 18		4% (2–8%)
Non-breast symptoms	7 (0–34) 105		10% (6–17%)
White	0 (0–1) 7	0.620c	2% (1–2%)
Non-white	0 (0–0) 10		1% (0.3–5%)
<50 years	0 (0–1) 15	0.016c	3% (2–5%)
50–69 years	0 (0–0) 4		1% (1–2%)
70+ years	0 (0–1) 3		1% (1–2%)

Bold denotes p < 0.05.

^aK19% and 5% of women had missing information on the patient interval and the primary care interval respectively.

^bKruskal-Wallis tests.

^cChi-squared tests.